Article
Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Surgery today - 1 Feb 2016
Mizuguchi Toru, Torigoe Toshihiko, Satomi Fukino, Shima Hiroaki, Kutomi Goro, Ota Shigenori, Ishii Masayuki, Hayashi Hiroshi, Asakura Sumiyo, Hirohashi Yoshihiko, Meguro Makoto, Kimura Yasutoshi, Nishidate Toshihiko, Okita Kenji, Ishino Masaho, Miyamoto Atsushi, Hatakenaka Masamitsu, Sato Noriyuki, Hirata Koichi
Abstract excerpt
Pancreatic tumors are chemoresistant and malignant, and there are very few therapeutic options for pancreatic cancer, as the disease is normally diagnosed at an advanced stage. Although attempts have been made to develop vaccine therapies for pancreatic cancer for a couple of decades, none of the resultant protocols or regimens have succeeded in improving the clinical outcomes of patients. We herein review...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.